Works by Park, Cheol Kyu


Results: 44
    1
    2

    Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.

    Published in:
    2018
    By:
    • In-Jae Oh;
    • Jae Young Hur;
    • Cheol-Kyu Park;
    • Young-Chul Kim;
    • Seung Joon Kim;
    • Min Ki Lee;
    • Hee Joung Kim;
    • Kye Young Lee;
    • Jae Cheol Lee;
    • Chang-Min Choi;
    • Oh, In-Jae;
    • Hur, Jae Young;
    • Park, Cheol-Kyu;
    • Kim, Young-Chul;
    • Kim, Seung Joon;
    • Lee, Min Ki;
    • Kim, Hee Joung;
    • Lee, Kye Young;
    • Lee, Jae Cheol;
    • Choi, Chang-Min
    Publication type:
    journal article
    3
    4
    5
    6

    Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 112, doi. 10.4143/crt.2022.381
    By:
    • Jang Ho Lee;
    • Eun Young Kim;
    • Cheol-Kyu Park;
    • Shin Yup Lee;
    • Min Ki Lee;
    • Seong-Hoon Yoon;
    • Jeong Eun Lee;
    • Sang Hoon Lee;
    • Seung Joon Kim;
    • Sung Yong Lee;
    • Jun Hyeok Lim;
    • Tae-Won Jang;
    • Seung Hun Jang;
    • Kye Young Lee;
    • Seung Hyeun Lee;
    • Sei Hoon Yang;
    • Dong Won Park;
    • Chan Kwon Park;
    • Hye Seon Kang;
    • Chang Dong Yeo
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea.

    Published in:
    Thoracic Cancer, 2024, v. 15, n. 6, p. 448, doi. 10.1111/1759-7714.15213
    By:
    • Jeon, Da Som;
    • Park, Cheol‐kyu;
    • Kim, Seung Joon;
    • Park, Chan Kwon;
    • Chang, Yoon Soo;
    • Jung, Chi Young;
    • Lee, Sung Yong;
    • Lee, Shin‐Yup;
    • Ryu, Jeong‐Seon;
    • Lee, Jeong Eun;
    • Lee, Kye Young;
    • Jang, Tae Won;
    • Jang, Seung Hun;
    • Yoon, Seong Hoon;
    • Lee, Sang Hoon;
    • Choi, Chang‐min;
    • Kim, Hyeong Ryul;
    • Kim, Yeon Joo
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 17, p. 5809, doi. 10.1002/cam4.4127
    By:
    • Kim, Taeyun;
    • Jang, Tae Won;
    • Choi, Chang Min;
    • Kim, Mi‐Hyun;
    • Lee, Sung Yong;
    • Park, Cheol‐Kyu;
    • Chang, Yoon Soo;
    • Lee, Kye Young;
    • Kim, Seung Joon;
    • Yang, Sei Hoon;
    • Ryu, Jeong Seon;
    • Lee, Jeong Eun;
    • Lee, Shin Yup;
    • Park, Chan Kwon;
    • Lee, Sang Hoon;
    • Jang, Seung Hun;
    • Yoon, Seong Hoon
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44